Growth Factor Signaling Induces Metastasis Genes in Transformed Cells: Molecular Connection between Akt Kinase and Osteopontin in Breast Cancer
Open Access
- 1 September 2003
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 23 (18) , 6507-6519
- https://doi.org/10.1128/mcb.23.18.6507-6519.2003
Abstract
Malignant tumors are characterized by excessive growth, immortalization, and metastatic spread, whereas benign tumors do not express gene products that mediate invasion. The molecular basis for this difference is incompletely understood. We have screened signal transduction molecules associated with the epidermal growth factor (EGF) receptor and have identified constitutive phosphorylation, indicative of activation, of Akt kinase in MT2994 breast cancer cells. In contrast, cells of the benign breast epithelial cell lines Comma-D and FSK-7 are immortalized through pathways that are independent of the EGF-phosphatidylinositol 3-kinase-Akt kinase cascade, but this is not associated with invasiveness. Transfection of constitutively active Akt kinase causes accelerated cell division and osteopontin expression. Conversely, dominant-negative Akt kinase slows cell cycle progression and suppresses osteopontin expression. The manipulation of osteopontin expression in this setting by transfection of the gene or its antisense does not affect the growth rate of the cells but alters cell motility and anchorage independence. Therefore, Akt kinase activates two distinct genetic programs: the program of growth and survival, which is independent of osteopontin expression, and the program of invasiveness and anchorage independence, which is mediated by osteopontin. These studies define Akt kinase as a molecular bridge between cell cycle progression and dissemination.Keywords
This publication has 57 references indexed in Scilit:
- ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growthOncogene, 2001
- CRBP suppresses breast cancer cell survival and anchorage-independent growthOncogene, 2001
- Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cellsOncogene, 2000
- Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cellsOncogene, 1999
- Activation of T cells by superantigen: cytokine production but not apoptosis depends on MEK-1 activityEuropean Journal of Immunology, 1998
- The LCC15-MB Human Breast Cancer Cell Line Expresses Osteopontin and Exhibits an Invasive and Metastatic PhenotypeExperimental Cell Research, 1998
- Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell lineOncogene, 1997
- Enhanced hepatocyte colony growth in soft agar after in vivo treatment with a genotoxic carcinogen: A potential assay for hepatocarcinogens?Cancer Letters, 1995
- Secreted phosphoprotein mrna is induced during multi‐stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblastsInternational Journal of Cancer, 1990
- Identification of the major phosphoprotein secreted by many rodent cell lines as 2AR/osteopontin: Enhanced expression in H-RAS-transformed 3T3 cellsBiochemical and Biophysical Research Communications, 1988